KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Change in Intangibles (2020 - 2025)

Ionis Pharmaceuticals (IONS) has 6 years of Change in Intangibles data on record, last reported at $1.4 million in Q4 2025.

  • For Q4 2025, Change in Intangibles fell 46.41% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $5.6 million, up 11.44%, while the annual FY2025 figure was $5.6 million, 11.44% up from the prior year.
  • Change in Intangibles reached $1.4 million in Q4 2025 per IONS's latest filing, down from $1.7 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at $14.0 million in Q2 2024 and bottomed at -$12.8 million in Q3 2024.
  • Average Change in Intangibles over 5 years is $1.3 million, with a median of $1.2 million recorded in 2023.
  • The widest YoY moves for Change in Intangibles: up 1222.05% in 2024, down 1259.09% in 2024.
  • A 5-year view of Change in Intangibles shows it stood at $1.5 million in 2021, then plummeted by 41.69% to $867000.0 in 2022, then decreased by 11.19% to $770000.0 in 2023, then surged by 230.78% to $2.5 million in 2024, then tumbled by 46.41% to $1.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Intangibles were $1.4 million in Q4 2025, $1.7 million in Q3 2025, and $2.0 million in Q2 2025.